Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming

Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is know...

Full description

Saved in:
Bibliographic Details
Published inThe FEBS journal Vol. 285; no. 14; pp. 2626 - 2640
Main Authors Conage‐Pough, Jason E., Boise, Lawrence H.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI‐WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence. Mcl‐1 is highly labile and frequently targeted for ubiquitination. Wild‐type Bim overexpression stabilized and preferentially primed Mcl‐1. Conversely, the introduction of several Bim phosphorylation site mutations resulted in the altered ability to stabilize Mcl‐1 and differential Bim binding to antiapoptotic proteins. Our findings suggest Bim phosphorylation influences Bcl‐2 family priming and dependence.
AbstractList Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.
Mcl-1 is a highly labile protein, subject to extensive posttranslational regulation. This distinguishes Mcl-1 from other anti-apoptotic proteins and necessitates further study to better understand how interactions with pro-apoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to anti-apoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.
Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI‐WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence. Mcl‐1 is highly labile and frequently targeted for ubiquitination. Wild‐type Bim overexpression stabilized and preferentially primed Mcl‐1. Conversely, the introduction of several Bim phosphorylation site mutations resulted in the altered ability to stabilize Mcl‐1 and differential Bim binding to antiapoptotic proteins. Our findings suggest Bim phosphorylation influences Bcl‐2 family priming and dependence.
Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.
Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl‐2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl‐1, and Bim phosphorylation has been associated with increased Mcl‐1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl‐1 stability. We found that Bim stabilizes and primes Mcl‐1 in RPCI ‐ WM 1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho‐mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl‐1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl‐1 stability but also is a potential mechanism for enforcing Mcl‐1 dependence.
Author Boise, Lawrence H.
Conage‐Pough, Jason E.
AuthorAffiliation 2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
1 Cancer Biology Graduate Program
AuthorAffiliation_xml – name: 2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
– name: 1 Cancer Biology Graduate Program
Author_xml – sequence: 1
  givenname: Jason E.
  surname: Conage‐Pough
  fullname: Conage‐Pough, Jason E.
  organization: Emory University
– sequence: 2
  givenname: Lawrence H.
  surname: Boise
  fullname: Boise, Lawrence H.
  email: lboise@emory.edu
  organization: Emory University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29775995$$D View this record in MEDLINE/PubMed
BookMark eNqFkd1qVDEUhYNUbDt64wPIAW9EmJr_nNwItrRVqCio4F3IyU8nJZOMyRlletVH8Bl9EjOdcdAimpsk5Ntrr-x1CPZSTg6AxwgeobZeeDfUI0QZZPfAARIUTyln_d7uTD_vg8NaryAkjEr5AOxjKQSTkh2A8_ezXBezXFZRjyGnTsfRldodh_mPm-9zZ4Mene3emtiuqKujHkIM11s22W5Rwjyky4fgvtexukfbfQI-nZ1-PHk9vXh3_ubk1cXUMCrYFCOHHRmMlnognAjiqcHcEmGtFc5w6HqEpbe90dRDRr32etA9ZFZ6wXVPJuDlRnexHJo749JYdFRrF7qsVNZB_fmSwkxd5q-KY8REm8AEPNsKlPxl6eqo5qEaF6NOLi-rwggiQnvJ-f9RSBGnkBLZ0Kd30Ku8LKlNolGCtN5Y0kY9-d38zvWvOBrwfAOYkmstzu8QBNU6a7XOWt1m3WB4BzZhvA2mfTzEv5egTcm3EN3qH-Lq7PT4w6bmJ3LyvmA
CitedBy_id crossref_primary_10_1182_blood_2019004326
crossref_primary_10_1038_s41419_022_05214_9
crossref_primary_10_1186_s13045_021_01079_1
crossref_primary_10_2174_1389203724666230822100131
crossref_primary_10_3389_fphar_2022_1032069
crossref_primary_10_3390_cells10030559
crossref_primary_10_1182_blood_2024024341
crossref_primary_10_1007_s10753_020_01240_x
crossref_primary_10_1038_s41467_024_50063_z
crossref_primary_10_1182_blood_2018_07_864207
crossref_primary_10_3389_fonc_2020_625199
crossref_primary_10_1016_j_clml_2022_07_013
crossref_primary_10_3389_fonc_2022_899272
crossref_primary_10_1016_j_compbiolchem_2025_108427
crossref_primary_10_1016_j_xcrm_2023_101007
crossref_primary_10_3389_fonc_2022_1005659
crossref_primary_10_7554_eLife_54954
crossref_primary_10_1016_j_xcrm_2023_101178
Cites_doi 10.1038/onc.2015.103
10.1016/j.febslet.2005.09.028
10.1038/cdd.2013.114
10.1073/pnas.0701297104
10.1074/jbc.M301010200
10.1038/nrm2952
10.1074/mcp.T600044-MCP200
10.18632/oncotarget.10847
10.1016/j.molcel.2004.12.030
10.1053/j.gastro.2008.12.064
10.1016/S1097-2765(01)00214-3
10.1073/pnas.0438011100
10.1016/S1097-2765(00)80456-6
10.1038/cddis.2014.561
10.1016/S1535-6108(02)00127-7
10.1038/nm.3048
10.1126/science.1092734
10.1093/carcin/bgp165
10.1038/ni.2527
10.1126/science.1106114
10.1016/1074-7613(95)90161-2
10.1074/jbc.M610010200
10.1016/j.bbrc.2007.07.070
10.1038/cdd.2013.78
10.1242/jcs.135137
10.3390/cells3020418
10.1002/1873-3468.12497
10.1038/nature08822
10.3109/10428194.2012.713481
10.1016/j.febslet.2010.05.061
10.1128/MCB.00620-06
10.1038/nchembio.2174
10.1074/jbc.M505546200
10.18632/oncotarget.20222
10.1016/j.molcel.2008.12.020
10.1038/cdd.2013.93
10.1074/jbc.M411434200
10.18632/oncotarget.9217
10.1182/blood-2004-10-3984
10.1016/j.bbamcr.2003.08.012
10.1016/j.molcel.2010.01.025
10.1016/j.exer.2016.08.002
10.1038/nature03579
10.1038/nature19830
10.1073/pnas.90.8.3516
10.1182/blood-2011-01-327197
10.1056/NEJMoa1513257
10.1101/gad.14.16.2060
10.1080/15384047.2014.1002333
10.1038/cdd.2011.198
10.1038/cdd.2014.209
10.1016/j.molcel.2012.05.040
10.1038/sj.cdd.4400783
10.1016/j.bbrc.2011.08.118
10.1186/s12885-017-3442-y
10.1016/0092-8674(92)90123-T
10.1073/pnas.0406837101
10.1016/j.molcel.2005.02.003
10.1038/cddis.2016.237
10.1038/nrd.2016.253
10.1016/j.molcel.2008.03.025
10.1158/0008-5472.CAN-07-5836
10.1038/leu.2015.350
10.1074/mcp.M700574-MCP200
10.1016/j.celrep.2014.07.057
10.1101/gad.1093903
10.1038/nature02067
10.1083/jcb.200904049
10.1038/sj.onc.1208873
10.1074/jbc.M114.569376
10.1038/sj.onc.1206792
10.1073/pnas.91.20.9238
10.1038/sj.emboj.7601723
10.1182/blood-2016-10-745059
10.1038/cdd.2013.79
10.1182/blood-2007-10-116889
ContentType Journal Article
Copyright 2018 Federation of European Biochemical Societies
2018 Federation of European Biochemical Societies.
Copyright © 2018 Federation of European Biochemical Societies
Copyright_xml – notice: 2018 Federation of European Biochemical Societies
– notice: 2018 Federation of European Biochemical Societies.
– notice: Copyright © 2018 Federation of European Biochemical Societies
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
5PM
DOI 10.1111/febs.14505
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Nucleic Acids Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE

Virology and AIDS Abstracts

AGRICOLA
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1742-4658
EndPage 2640
ExternalDocumentID PMC6215700
29775995
10_1111_febs_14505
FEBS14505
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: UNCF‐Merck Foundation
– fundername: National Cancer Institute
  funderid: R01 CA192844
– fundername: NCI NIH HHS
  grantid: R01 CA192844
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29H
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEFU
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EAS
EAU
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HH5
HZI
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RNS
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBFHL
WBKPD
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
X7M
XG1
Y6R
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7TK
7TM
7U9
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c5475-21e2e3bca9ab36373f4c26d37ddd7ec60e8129fd8ca4f054fafaba805d9f76a83
IEDL.DBID DR2
ISSN 1742-464X
1742-4658
IngestDate Thu Aug 21 18:42:34 EDT 2025
Fri Jul 11 18:38:25 EDT 2025
Fri Jul 11 15:11:54 EDT 2025
Fri Jul 25 19:36:56 EDT 2025
Thu Apr 03 07:02:47 EDT 2025
Thu Apr 24 23:11:50 EDT 2025
Tue Jul 01 03:06:48 EDT 2025
Wed Jan 22 16:20:51 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords priming
Bim phosphorylation
Mcl-1 stability
Language English
License 2018 Federation of European Biochemical Societies.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5475-21e2e3bca9ab36373f4c26d37ddd7ec60e8129fd8ca4f054fafaba805d9f76a83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author Contributions
JEC-P and LHB conceived the study, designed the experiments, and wrote and revised the manuscript. JEC-P performed the experiments and LHB supervised the study.
OpenAccessLink https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.14505
PMID 29775995
PQID 2073215294
PQPubID 28478
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6215700
proquest_miscellaneous_2101348966
proquest_miscellaneous_2041640439
proquest_journals_2073215294
pubmed_primary_29775995
crossref_primary_10_1111_febs_14505
crossref_citationtrail_10_1111_febs_14505
wiley_primary_10_1111_febs_14505_FEBS14505
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2018
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: July 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle The FEBS journal
PublicationTitleAlternate FEBS J
PublicationYear 2018
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 11
2007; 104
2017; 8
2011; 118
2013; 20
2000; 7
2005; 579
2010; 584
2010; 463
2008; 7
2016; 30
2012; 19
2003; 17
2017; 591
2008; 30
2003; 278
2016; 35
2005; 24
2013; 19
2014; 127
2013; 14
2014; 3
2000; 14
2013; 54
2005; 105
2005; 307
2007; 6
2008; 68
2006; 281
2014; 8
2008; 111
1996; 2
2016; 151
2007; 26
2014; 289
2007; 27
2017; 129
2011; 413
2004; 101
2004; 303
2015; 6
2010; 37
2015; 16
2007; 282
2007; 361
2005; 435
2002; 2
1993; 90
1999; 3
1995; 3
2009; 136
2004; 1644
2016; 12
2009; 33
2005; 280
2016; 7
2009; 30
2003; 426
2001; 7
2016; 538
2017; 17
2017; 16
2015; 22
2009; 187
2016; 374
1992; 69
2012; 47
1994; 91
2005; 17
2003; 100
2003; 22
e_1_2_9_75_1
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_77_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_71_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_76_1
e_1_2_9_70_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
Kumar R (e_1_2_9_20_1) 1996; 2
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_69_1
e_1_2_9_29_1
References_xml – volume: 7
  start-page: 1598
  year: 2008
  end-page: 1608
  article-title: GPS 2.0, a tool to predict kinase‐specific phosphorylation sites in hierarchy
  publication-title: Mol Cell Proteomics
– volume: 2
  start-page: 1215
  year: 1996
  end-page: 1219
  article-title: Overexpression of HER2 modulates bcl‐2, bcl‐XL, and tamoxifen‐induced apoptosis in human MCF‐7 breast cancer cells
  publication-title: Clin Cancer Res
– volume: 280
  start-page: 4738
  year: 2005
  end-page: 4744
  article-title: Solution structure of prosurvival Mcl‐1 and characterization of its binding by proapoptotic BH3‐only ligands
  publication-title: J Biol Chem
– volume: 435
  start-page: 677
  year: 2005
  end-page: 681
  article-title: An inhibitor of Bcl‐2 family proteins induces regression of solid tumours
  publication-title: Nature
– volume: 2
  start-page: 183
  year: 2002
  end-page: 192
  article-title: Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
  publication-title: Cancer Cell
– volume: 281
  start-page: 813
  year: 2006
  end-page: 823
  article-title: Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function
  publication-title: J Biol Chem
– volume: 278
  start-page: 18811
  year: 2003
  end-page: 18816
  article-title: Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome‐dependent degradation of the BH3‐only protein, Bim
  publication-title: J Biol Chem
– volume: 289
  start-page: 23629
  year: 2014
  end-page: 23640
  article-title: Bcl‐xL protein protects from C/EBP homologous protein (CHOP)‐dependent apoptosis during plasma cell differentiation
  publication-title: J Biol Chem
– volume: 14
  start-page: 290
  year: 2013
  end-page: 297
  article-title: Mcl‐1 is essential for the survival of plasma cells
  publication-title: Nat Immunol
– volume: 20
  start-page: 1317
  year: 2013
  end-page: 1329
  article-title: Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK
  publication-title: Cell Death Differ
– volume: 20
  start-page: 1475
  year: 2013
  end-page: 1484
  article-title: Evaluation and critical assessment of putative MCL‐1 inhibitors
  publication-title: Cell Death Differ
– volume: 463
  start-page: 899
  year: 2010
  end-page: 905
  article-title: The landscape of somatic copy‐number alteration across human cancers
  publication-title: Nature
– volume: 538
  start-page: 477
  year: 2016
  end-page: 482
  article-title: The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
  publication-title: Nature
– volume: 19
  start-page: 202
  year: 2013
  end-page: 208
  article-title: ABT‐199, a potent and selective BCL‐2 inhibitor, achieves antitumor activity while sparing platelets
  publication-title: Nat Med
– volume: 30
  start-page: 1086
  year: 2016
  end-page: 1093
  article-title: Dexamethasone treatment promotes Bcl‐2 dependence in multiple myeloma resulting in sensitivity to venetoclax
  publication-title: Leukemia
– volume: 7
  start-page: 36353
  year: 2016
  end-page: 36365
  article-title: DNA damaging agent‐induced apoptosis is regulated by MCL‐1 phosphorylation and degradation mediated by the Noxa/MCL‐1/CDK2 complex
  publication-title: Oncotarget
– volume: 7
  start-page: 59727
  year: 2016
  end-page: 59741
  article-title: Bortezomib‐induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation
  publication-title: Oncotarget
– volume: 24
  start-page: 7224
  year: 2005
  end-page: 7237
  article-title: Puma(*)Mcl‐1 interaction is not sufficient to prevent rapid degradation of Mcl‐1
  publication-title: Oncogene
– volume: 14
  start-page: 2060
  year: 2000
  end-page: 2071
  article-title: tBID, a membrane‐targeted death ligand, oligomerizes BAK to release cytochrome c
  publication-title: Genes Dev
– volume: 54
  start-page: 387
  year: 2013
  end-page: 396
  article-title: Development and characterization of a novel human Waldenstrom macroglobulinemia cell line: RPCI‐WM1, Roswell Park Cancer Institute ‐ Waldenstrom Macroglobulinemia 1
  publication-title: Leuk Lymphoma
– volume: 136
  start-page: 1423
  year: 2009
  end-page: 1434
  article-title: Antiapoptotic effect of c‐Jun N‐terminal Kinase‐1 through Mcl‐1 stabilization in TNF‐induced hepatocyte apoptosis
  publication-title: Gastroenterology
– volume: 17
  start-page: 525
  year: 2005
  end-page: 535
  article-title: BH3 domains of BH3‐only proteins differentially regulate Bax‐mediated mitochondrial membrane permeabilization both directly and indirectly
  publication-title: Mol Cell
– volume: 8
  start-page: 1347
  year: 2014
  end-page: 1353
  article-title: BIM is the primary mediator of MYC‐induced apoptosis in multiple solid tissues
  publication-title: Cell Rep
– volume: 127
  start-page: 2217
  year: 2014
  end-page: 2226
  article-title: Procaspase‐3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function
  publication-title: J Cell Sci
– volume: 17
  start-page: 449
  year: 2017
  article-title: Targeting MCL‐1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin‐induced apoptosis
  publication-title: BMC Cancer
– volume: 22
  start-page: 1275
  year: 2015
  end-page: 1286
  article-title: Anoikis evasion in inflammatory breast cancer cells is mediated by Bim‐EL sequestration
  publication-title: Cell Death Differ
– volume: 413
  start-page: 460
  year: 2011
  end-page: 464
  article-title: Noxa controls Mule‐dependent Mcl‐1 ubiquitination through the regulation of the Mcl‐1/USP9X interaction
  publication-title: Biochem Biophys Res Commun
– volume: 303
  start-page: 1010
  year: 2004
  end-page: 1014
  article-title: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
  publication-title: Science
– volume: 19
  start-page: 1060
  year: 2012
  end-page: 1068
  article-title: Alternative splicing of Bim and Erk‐mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis
  publication-title: Cell Death Differ
– volume: 307
  start-page: 1101
  year: 2005
  end-page: 1104
  article-title: Obligate role of anti‐apoptotic MCL‐1 in the survival of hematopoietic stem cells
  publication-title: Science
– volume: 104
  start-page: 6217
  year: 2007
  end-page: 6222
  article-title: Structural insights into the degradation of Mcl‐1 induced by BH3 domains
  publication-title: Proc Natl Acad Sci USA
– volume: 33
  start-page: 109
  year: 2009
  end-page: 116
  article-title: betaTrCP‐ and Rsk1/2‐mediated degradation of BimEL inhibits apoptosis
  publication-title: Mol Cell
– volume: 20
  start-page: 1393
  year: 2013
  end-page: 1403
  article-title: BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by betaTrCP1
  publication-title: Cell Death Differ
– volume: 426
  start-page: 671
  year: 2003
  end-page: 676
  article-title: Development and maintenance of B and T lymphocytes requires antiapoptotic MCL‐1
  publication-title: Nature
– volume: 22
  start-page: 6785
  year: 2003
  end-page: 6793
  article-title: Phosphorylation of Bim‐EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
  publication-title: Oncogene
– volume: 1644
  start-page: 83
  year: 2004
  end-page: 94
  article-title: Structural biology of the Bcl‐2 family of proteins
  publication-title: Biochim Biophys Acta
– volume: 37
  start-page: 299
  year: 2010
  end-page: 310
  article-title: The BCL‐2 family reunion
  publication-title: Mol Cell
– volume: 69
  start-page: 119
  year: 1992
  end-page: 128
  article-title: Induction of apoptosis in fibroblasts by c‐myc protein
  publication-title: Cell
– volume: 101
  start-page: 15313
  year: 2004
  end-page: 15317
  article-title: Survival factor‐induced extracellular signal‐regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity
  publication-title: Proc Natl Acad Sci USA
– volume: 361
  start-page: 865
  year: 2007
  end-page: 869
  article-title: Reciprocal protection of Mcl‐1 and Bim from ubiquitin‐proteasome degradation
  publication-title: Biochem Biophys Res Commun
– volume: 12
  start-page: 931
  year: 2016
  end-page: 936
  article-title: Inhibition of Mcl‐1 through covalent modification of a noncatalytic lysine side chain
  publication-title: Nat Chem Biol
– volume: 35
  start-page: 479
  year: 2016
  end-page: 490
  article-title: Low expression of pro‐apoptotic Bcl‐2 family proteins sets the apoptotic threshold in Waldenstrom macroglobulinemia
  publication-title: Oncogene
– volume: 105
  start-page: 3255
  year: 2005
  end-page: 3262
  article-title: Evidence for a protective role of Mcl‐1 in proteasome inhibitor‐induced apoptosis
  publication-title: Blood
– volume: 17
  start-page: 1475
  year: 2003
  end-page: 1486
  article-title: Elimination of Mcl‐1 is required for the initiation of apoptosis following ultraviolet irradiation
  publication-title: Genes Dev
– volume: 7
  start-page: 683
  year: 2001
  end-page: 694
  article-title: PUMA, a novel proapoptotic gene, is induced by p53
  publication-title: Mol Cell
– volume: 584
  start-page: 2981
  year: 2010
  end-page: 2989
  article-title: Mcl‐1; the molecular regulation of protein function
  publication-title: FEBS Lett
– volume: 16
  start-page: 273
  year: 2017
  end-page: 284
  article-title: From basic apoptosis discoveries to advanced selective BCL‐2 family inhibitors
  publication-title: Nat Rev Drug Discov
– volume: 591
  start-page: 240
  year: 2017
  end-page: 251
  article-title: Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors
  publication-title: FEBS Lett
– volume: 91
  start-page: 9238
  year: 1994
  end-page: 9242
  article-title: Interactions among members of the Bcl‐2 protein family analyzed with a yeast two‐hybrid system
  publication-title: Proc Natl Acad Sci USA
– volume: 7
  start-page: 1166
  year: 2000
  end-page: 1173
  article-title: Pro‐apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c
  publication-title: Cell Death Differ
– volume: 17
  start-page: 393
  year: 2005
  end-page: 403
  article-title: Differential targeting of prosurvival Bcl‐2 proteins by their BH3‐only ligands allows complementary apoptotic function
  publication-title: Mol Cell
– volume: 90
  start-page: 3516
  year: 1993
  end-page: 3520
  article-title: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2
  publication-title: Proc Natl Acad Sci USA
– volume: 47
  start-page: 359
  year: 2012
  end-page: 370
  article-title: Bim inhibits autophagy by recruiting Beclin 1 to microtubules
  publication-title: Mol Cell
– volume: 26
  start-page: 2856
  year: 2007
  end-page: 2867
  article-title: ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL
  publication-title: EMBO J
– volume: 68
  start-page: 3421
  year: 2008
  end-page: 3428
  article-title: ABT‐263: a potent and orally bioavailable Bcl‐2 family inhibitor
  publication-title: Cancer Res
– volume: 20
  start-page: 1440
  year: 2013
  end-page: 1441
  article-title: Seeking a MCL‐1 inhibitor
  publication-title: Cell Death Differ
– volume: 579
  start-page: 5603
  year: 2005
  end-page: 5608
  article-title: BH3‐ligand regulates access of MCL‐1 to its E3 ligase
  publication-title: FEBS Lett
– volume: 3
  start-page: 418
  year: 2014
  end-page: 437
  article-title: Mcl‐1 ubiquitination: unique regulation of an essential survival protein
  publication-title: Cells
– volume: 27
  start-page: 4006
  year: 2007
  end-page: 4017
  article-title: Degradation of Mcl‐1 by beta‐TrCP mediates glycogen synthase kinase 3‐induced tumor suppression and chemosensitization
  publication-title: Mol Cell Biol
– volume: 16
  start-page: 276
  year: 2015
  end-page: 286
  article-title: EGFR signaling defines Mcl(‐)1 survival dependency in neuroblastoma
  publication-title: Cancer Biol Ther
– volume: 6
  start-page: 356
  year: 2007
  end-page: 366
  article-title: Label‐free kinase profiling using phosphate affinity polyacrylamide gel electrophoresis
  publication-title: Mol Cell Proteomics
– volume: 129
  start-page: 1969
  year: 2017
  end-page: 1979
  article-title: Bone marrow microenvironment‐derived signals induce Mcl‐1 dependence in multiple myeloma
  publication-title: Blood
– volume: 282
  start-page: 18407
  year: 2007
  end-page: 18417
  article-title: Serine 64 phosphorylation enhances the antiapoptotic function of Mcl‐1
  publication-title: J Biol Chem
– volume: 187
  start-page: 429
  year: 2009
  end-page: 442
  article-title: MCL‐1‐dependent leukemia cells are more sensitive to chemotherapy than BCL‐2‐dependent counterparts
  publication-title: J Cell Biol
– volume: 100
  start-page: 2432
  year: 2003
  end-page: 2437
  article-title: JNK phosphorylation of Bim‐related members of the Bcl2 family induces Bax‐dependent apoptosis
  publication-title: Proc Natl Acad Sci USA
– volume: 3
  start-page: 87
  year: 1995
  end-page: 98
  article-title: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl‐XL
  publication-title: Immunity
– volume: 7
  start-page: e2345
  year: 2016
  article-title: MCL‐1 is required throughout B‐cell development and its loss sensitizes specific B‐cell subsets to inhibition of BCL‐2 or BCL‐XL
  publication-title: Cell Death Dis
– volume: 6
  start-page: e1590
  year: 2015
  article-title: Potent and selective small‐molecule MCL‐1 inhibitors demonstrate on‐target cancer cell killing activity as single agents and in combination with ABT‐263 (navitoclax)
  publication-title: Cell Death Dis
– volume: 118
  start-page: 1329
  year: 2011
  end-page: 1339
  article-title: Distribution of Bim determines Mcl‐1 dependence or codependence with Bcl‐xL/Bcl‐2 in Mcl‐1‐expressing myeloma cells
  publication-title: Blood
– volume: 11
  start-page: 621
  year: 2010
  end-page: 632
  article-title: Mitochondria and cell death: outer membrane permeabilization and beyond
  publication-title: Nat Rev Mol Cell Biol
– volume: 30
  start-page: 1517
  year: 2009
  end-page: 1527
  article-title: Cisplatin overcomes Bcl‐2‐mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa‐mediated lipid peroxidation
  publication-title: Carcinogenesis
– volume: 30
  start-page: 415
  year: 2008
  end-page: 425
  article-title: Multisite phosphorylation regulates Bim stability and apoptotic activity
  publication-title: Mol Cell
– volume: 374
  start-page: 311
  year: 2016
  end-page: 322
  article-title: Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
  publication-title: N Engl J Med
– volume: 151
  start-page: 82
  year: 2016
  end-page: 95
  article-title: Insulin‐like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK‐mediated BimEL phosphorylation independent of Akt
  publication-title: Exp Eye Res
– volume: 3
  start-page: 287
  year: 1999
  end-page: 296
  article-title: The proapoptotic activity of the Bcl‐2 family member Bim is regulated by interaction with the dynein motor complex
  publication-title: Mol Cell
– volume: 8
  start-page: 82981
  year: 2017
  end-page: 82990
  article-title: Mcl‐1 stabilization confers resistance to taxol in human gastric cancer
  publication-title: Oncotarget
– volume: 111
  start-page: 5152
  year: 2008
  end-page: 5162
  article-title: BH3‐only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide‐induced cell death in myeloma
  publication-title: Blood
– ident: e_1_2_9_39_1
  doi: 10.1038/onc.2015.103
– ident: e_1_2_9_31_1
  doi: 10.1016/j.febslet.2005.09.028
– ident: e_1_2_9_69_1
  doi: 10.1038/cdd.2013.114
– volume: 2
  start-page: 1215
  year: 1996
  ident: e_1_2_9_20_1
  article-title: Overexpression of HER2 modulates bcl‐2, bcl‐XL, and tamoxifen‐induced apoptosis in human MCF‐7 breast cancer cells
  publication-title: Clin Cancer Res
– ident: e_1_2_9_29_1
  doi: 10.1073/pnas.0701297104
– ident: e_1_2_9_36_1
  doi: 10.1074/jbc.M301010200
– ident: e_1_2_9_8_1
  doi: 10.1038/nrm2952
– ident: e_1_2_9_76_1
  doi: 10.1074/mcp.T600044-MCP200
– ident: e_1_2_9_40_1
  doi: 10.18632/oncotarget.10847
– ident: e_1_2_9_11_1
  doi: 10.1016/j.molcel.2004.12.030
– ident: e_1_2_9_24_1
  doi: 10.1053/j.gastro.2008.12.064
– ident: e_1_2_9_52_1
  doi: 10.1016/S1097-2765(01)00214-3
– ident: e_1_2_9_32_1
  doi: 10.1073/pnas.0438011100
– ident: e_1_2_9_59_1
  doi: 10.1016/S1097-2765(00)80456-6
– ident: e_1_2_9_66_1
  doi: 10.1038/cddis.2014.561
– ident: e_1_2_9_6_1
  doi: 10.1016/S1535-6108(02)00127-7
– ident: e_1_2_9_67_1
  doi: 10.1038/nm.3048
– ident: e_1_2_9_3_1
  doi: 10.1126/science.1092734
– ident: e_1_2_9_18_1
  doi: 10.1093/carcin/bgp165
– ident: e_1_2_9_12_1
  doi: 10.1038/ni.2527
– ident: e_1_2_9_14_1
  doi: 10.1126/science.1106114
– ident: e_1_2_9_77_1
  doi: 10.1016/1074-7613(95)90161-2
– ident: e_1_2_9_23_1
  doi: 10.1074/jbc.M610010200
– ident: e_1_2_9_28_1
  doi: 10.1016/j.bbrc.2007.07.070
– ident: e_1_2_9_44_1
  doi: 10.1038/cdd.2013.78
– ident: e_1_2_9_75_1
  doi: 10.1242/jcs.135137
– ident: e_1_2_9_49_1
  doi: 10.3390/cells3020418
– ident: e_1_2_9_65_1
  doi: 10.1002/1873-3468.12497
– ident: e_1_2_9_72_1
  doi: 10.1038/nature08822
– ident: e_1_2_9_73_1
  doi: 10.3109/10428194.2012.713481
– ident: e_1_2_9_21_1
  doi: 10.1016/j.febslet.2010.05.061
– ident: e_1_2_9_25_1
  doi: 10.1128/MCB.00620-06
– ident: e_1_2_9_71_1
  doi: 10.1038/nchembio.2174
– ident: e_1_2_9_43_1
  doi: 10.1074/jbc.M505546200
– ident: e_1_2_9_17_1
  doi: 10.18632/oncotarget.20222
– ident: e_1_2_9_35_1
  doi: 10.1016/j.molcel.2008.12.020
– ident: e_1_2_9_34_1
  doi: 10.1038/cdd.2013.93
– ident: e_1_2_9_10_1
  doi: 10.1074/jbc.M411434200
– ident: e_1_2_9_26_1
  doi: 10.18632/oncotarget.9217
– ident: e_1_2_9_48_1
  doi: 10.1182/blood-2004-10-3984
– ident: e_1_2_9_60_1
  doi: 10.1016/j.bbamcr.2003.08.012
– ident: e_1_2_9_2_1
  doi: 10.1016/j.molcel.2010.01.025
– ident: e_1_2_9_33_1
  doi: 10.1016/j.exer.2016.08.002
– ident: e_1_2_9_63_1
  doi: 10.1038/nature03579
– ident: e_1_2_9_46_1
  doi: 10.1038/nature19830
– ident: e_1_2_9_22_1
  doi: 10.1073/pnas.90.8.3516
– ident: e_1_2_9_53_1
  doi: 10.1182/blood-2011-01-327197
– ident: e_1_2_9_68_1
  doi: 10.1056/NEJMoa1513257
– ident: e_1_2_9_7_1
  doi: 10.1101/gad.14.16.2060
– ident: e_1_2_9_55_1
  doi: 10.1080/15384047.2014.1002333
– ident: e_1_2_9_61_1
  doi: 10.1038/cdd.2011.198
– ident: e_1_2_9_42_1
  doi: 10.1038/cdd.2014.209
– ident: e_1_2_9_58_1
  doi: 10.1016/j.molcel.2012.05.040
– ident: e_1_2_9_4_1
  doi: 10.1038/sj.cdd.4400783
– ident: e_1_2_9_30_1
  doi: 10.1016/j.bbrc.2011.08.118
– ident: e_1_2_9_19_1
  doi: 10.1186/s12885-017-3442-y
– ident: e_1_2_9_50_1
  doi: 10.1016/0092-8674(92)90123-T
– ident: e_1_2_9_37_1
  doi: 10.1073/pnas.0406837101
– ident: e_1_2_9_5_1
  doi: 10.1016/j.molcel.2005.02.003
– ident: e_1_2_9_13_1
  doi: 10.1038/cddis.2016.237
– ident: e_1_2_9_62_1
  doi: 10.1038/nrd.2016.253
– ident: e_1_2_9_45_1
  doi: 10.1016/j.molcel.2008.03.025
– ident: e_1_2_9_64_1
  doi: 10.1158/0008-5472.CAN-07-5836
– ident: e_1_2_9_78_1
  doi: 10.1038/leu.2015.350
– ident: e_1_2_9_41_1
  doi: 10.1074/mcp.M700574-MCP200
– ident: e_1_2_9_51_1
  doi: 10.1016/j.celrep.2014.07.057
– ident: e_1_2_9_47_1
  doi: 10.1101/gad.1093903
– ident: e_1_2_9_15_1
  doi: 10.1038/nature02067
– ident: e_1_2_9_54_1
  doi: 10.1083/jcb.200904049
– ident: e_1_2_9_27_1
  doi: 10.1038/sj.onc.1208873
– ident: e_1_2_9_16_1
  doi: 10.1074/jbc.M114.569376
– ident: e_1_2_9_57_1
  doi: 10.1038/sj.onc.1206792
– ident: e_1_2_9_9_1
  doi: 10.1073/pnas.91.20.9238
– ident: e_1_2_9_56_1
  doi: 10.1038/sj.emboj.7601723
– ident: e_1_2_9_38_1
  doi: 10.1182/blood-2016-10-745059
– ident: e_1_2_9_70_1
  doi: 10.1038/cdd.2013.79
– ident: e_1_2_9_74_1
  doi: 10.1182/blood-2007-10-116889
SSID ssj0035499
Score 2.3657148
Snippet Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and...
Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and...
Mcl-1 is a highly labile protein, subject to extensive posttranslational regulation. This distinguishes Mcl-1 from other anti-apoptotic proteins and...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2626
SubjectTerms Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Apoptosis - genetics
Bcl-2-Like Protein 11 - genetics
Bcl-2-Like Protein 11 - metabolism
bcl-X Protein - genetics
bcl-X Protein - metabolism
Bim phosphorylation
Binding
Bortezomib - pharmacology
Cell Line, Tumor
Dependence
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Mcl‐1 stability
Mutation
Myeloid Cell Leukemia Sequence 1 Protein - genetics
Myeloid Cell Leukemia Sequence 1 Protein - metabolism
Myeloid Cells - drug effects
Myeloid Cells - metabolism
Myeloid Cells - pathology
Phosphorylation
Phosphorylation - drug effects
Plasma Cells - drug effects
Plasma Cells - metabolism
Plasma Cells - pathology
Priming
Protein Binding
Protein Processing, Post-Translational
Protein Stability
Proteins
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
Signal Transduction
Stability
Title Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ffebs.14505
https://www.ncbi.nlm.nih.gov/pubmed/29775995
https://www.proquest.com/docview/2073215294
https://www.proquest.com/docview/2041640439
https://www.proquest.com/docview/2101348966
https://pubmed.ncbi.nlm.nih.gov/PMC6215700
Volume 285
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6U-qAvXlq10VpGFEEhJclkZhLoy27btQgVUQv7ImFucYttdml2H9onf4K_0V_SM5NLu1YK-paQE5jLOTPfzHzzHYDX3MZM0kiGihmBCxRpQilyHSboHNqanGuv0334kR8cpR_GbLwCO91dmEYfot9wc5Hhx2sX4FLV14K8tKrGOGdewNSRtRwi-txrR1G38GluQyZhytNxq03qaDxXvy7PRjcg5k2m5HUE66eg0QP41hW-YZ782F7M1ba--EPX8X9r9xDut9iUDBpnegQrtlqD9UGF6_LTc_KGeLao34Zfg7u7Xaa4dXj_aTKtZ5Pp2XlDrCP-CL4mw-PT3z9_-bspiGvJoT7B15ggHnWM3IvWtjJk5nOLfX8MR6P9r7sHYZugIdQsFSxMYptYqrTMpaKcClqmOuGGCmOMsJpHFuFDXppMy7REbFjKUiqZRczkpeAyo09gtZpWdgNIFpeJ1ArhCJWp9pI4jDGZ6SiWLMtVAG-7jip0q17ukmicFN0qxrVY4VssgFe97azR7Pir1WbX30Ubt3WR4IjnMv3maQAv-8_YnO4YRVZ2unA2CGKdKFF-iw2OdBQrwXkATxsX6ouSIOR2Mm8BiCXn6g2c4vfyl-p44pW_OZZNRFEA77zv3FK7YrQ__OKfnv2L8XO4h12QNXzkTVidny3sC0Rdc7UFdwbDveFoy0fZJcOqLaI
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qZVE2BVoegQJGPCSQUiVO7CQLFn0NU9qpELTS7IJjO52KNhl1ZoSmKz6BH-FX-Ai-hGvnQYeiSiy6YJcoV5Ef99rnJsfnAjzn2mci8ISbMRVhgiKUK6JEuhSdQ2qVcGl1unt7vHsQvuuz_hx8b87CVPoQ7Qc3Exl2vTYBbj5In4vyXGcjDHTcwmtO5Y6efsGMbfRmexOn9wWlna39ja5bFxVwJQsj5lJfUx1kUiQiC3gQBXkoKVdBpJSKtOSexi0vyVUsRZgjnslFLjIRe0wlecRFHOB7r8F1U0LcSPVvfmjVqgKTalXnL6kb8rBfq6Ea4tDvts7ufxdA7UVu5nnMbDe9zk340QxXxXX5vDoZZ6vy7A8lyf9mPG_BYg2_yVoVL7dhThdLsLxWiHF5MiUviSXE2j8NS7Cw0RTDW4a37wflaDgoT6cVd5BYlsGIrB-d_Pz6zR6_QehOevIYb32CkNuQjs9q20KRoS2fdngHDq6ke3dhvigLfR9I7OdUyAwRVyBCaVV_GGMilp4vWJxkDrxqPCOVtUC7qRNynDaJmpmh1M6QA89a22ElS_JXq5XGwdJ6aRqlFBd1U8w4CR142j7G4TR_ikShy4mxQZxudJeSS2xwMQ-wE5w7cK_y2bYpFLMKo2TnQDTjza2BETWffVIcDay4Oce2RZ7nwGvrrJf0Lu1srX-0Vw_-xfgJLHT3e7vp7vbezkO4gdMRV_TrFZgfn070IwSZ4-yxDW0Cn67a938BQmqM4g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qRQI2PFoegQJGPCSQUiV24iQLFm2nQ0tpVUErzS44tsNUtMmomRGarvgEPoRf4Sf4Eq6dBx2KKrHogl2iXEV-3GufmxyfC_CMaz8UzBNuFqoIExShXBEl0qXoHFKrhEur0729wzf2g7eDcDAH39uzMLU-RPfBzUSGXa9NgI9UfirIc51VGOe4gzeUyi09_YIJW_V6s4ez-5zS_vre2obb1BRwZRhEoUt9TTXLpEhExjiLWB5IyhWLlFKRltzTuOMluYqlCHKEM7nIRSZiL1RJHnERM3zvJbgccC8xhSJ67zuxKmYyrfr4JXUDHgwaMVTDG_rd1tnt7wymPUvNPA2Z7Z7XvwE_2tGqqS6flyfjbFme_CEk-b8M50243oBvslJHyy2Y08UCLK4UYlweTckLYumw9j_DAlxda0vhLcKb3WFZjYbl8bRmDhLLMajI6sHRz6_f7OEbBO5kWx7irU8QcBvK8UljWygyssXTPt2G_Qvp3h2YL8pC3wMS-zkVMkO8xUQgreZPGIYilp4vwjjJHHjZOkYqG3l2UyXkMG3TNDNDqZ0hB552tqNalOSvVkutf6XNwlSlFJd0U8o4CRx40j3G4TT_iUShy4mxQZRuVJeSc2xwKWfYCc4duFu7bNcUijmF0bFzIJpx5s7ASJrPPikOhlbanGPbIs9z4JX11XN6l_bXVz_Yq_v_YvwYruz2-um7zZ2tB3ANZyOuuddLMD8-nuiHiDDH2SMb2AQ-XrTr_wIT6YuR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phosphorylation+alters+Bim-mediated+Mcl-1+stabilization+and+priming&rft.jtitle=The+FEBS+journal&rft.au=Conage-Pough%2C+Jason+E&rft.au=Boise%2C+Lawrence+H&rft.date=2018-07-01&rft.eissn=1742-4658&rft.volume=285&rft.issue=14&rft.spage=2626&rft_id=info:doi/10.1111%2Ffebs.14505&rft_id=info%3Apmid%2F29775995&rft.externalDocID=29775995
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-464X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-464X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-464X&client=summon